vimarsana.com

Page 11 - Vaxxinity Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vaxxinity Announces Publication of UB-311 Safety, Tolerability, Immunogenicity, and Clinical

Vaxxinity, Inc (VAXX) Files $300M Mixed Shelf

Vaxxinity, Inc (VAXX) Files $300M Mixed Shelf
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Vaxxinity Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Vaxxinity Appoints Dr Peter Powchik as Global Scientific Director

By Daniella Parra Vaxxinity, Inc. (Nasdaq: VAXX) said it appointed Peter Powchik, M.D. as Executive Vice President, Global Scientific Director overseeing its scientific direction and lead development efforts. Powchik was previously Senior Vice President at Regeneron Pharmaceuticals, the company said. Additionally, Ulo Palm, M.D., will transition from Chief Medical Officer to senior advisor, it said. […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.